Expert Panel Recommends FDA Approve Alzheimer's Drug

Advisers vote unanimously to back donanemab despite risks
By Newser Editors and Wire Services
Posted Jun 10, 2024 6:45 PM CDT
More News: Health | Sports | World | Entertainment | Business